JMP Securities lowered the firm’s price target on Ibotta (IBTA) to $85 from $111 and keeps an Outperform rating on the shares. Ibotta ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

Fintel reports that on November 7, 2024, JMP Securities downgraded their outlook for MacroGenics (NasdaqGS:MGNX) from Market ...

JMP Securities raised the firm’s price target on Expensify (EXFY) to $3.25 from $2.50 and keeps a Market Perform rating on the shares after “mostly better than expected” Q3 earnings.

Reddit's ability to ensure more human conversation has broadened its appeal and helped it become a place for people not ...

Investing.com -- Snap shares rose 2% in premarket trading Wednesday after JMP Securities analysts upgraded the stock from Market Perform to Outperform and set a price target of $17. The firm’s ...

JMP Securities downgraded Nerdy (NRDY) to Market Perform from Outperform without a price target The company reported Q3 results that came in slightly better than consensus revenue and EBITDA ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

The U.S. presidential election is an important short-term catalyst for Coinbase and the wider industry, and could lead to ...

Ladies and gentlemen, thank you for standing by. Welcome to Qualys third-quarter 2024 investor call. (Operator Instructions) Please be advised that today's conference is being recorded. I would like ...

Oddity Tech (NASDAQ: ODD) Q3 2024 Earnings Call Nov 07, 2024, 8:30 a.m. ET ...